EPIMS
INDV icon

Evelyn Partners Investment Management Services’s Indivior Pharmaceuticals INDV Stock Holding History

Evelyn Partners Investment Management Services’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.7K Hold
2,745
– – 0.01% 154
2025
Q4 		$98.5K Sell
2,745
-850
-24% -$26K 0.01% 148
2025
Q3 		$86.7K Sell
3,595
-54,396
-94% -$1.14M 0.01% 152
2025
Q2 		$855K Hold
57,991
– – 0.13% 85
2025
Q1 		$553K Sell
57,991
-158
-0.3% -$1.66K 0.09% 95
2024
Q4 		$723K Buy
+58,149
New +$598K 0.13% 80

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Evelyn Partners Investment Management Services's INDV Position: Q1 2026 in Review

Evelyn Partners Investment Management Services held its Indivior Pharmaceuticals (INDV) position steady in Q1 2026 at 2,745 shares worth $83.7K. The position accounts for 0.01% of the portfolio, ranked #154.

Evelyn Partners Investment Management Services first reported a position in INDV in Q4 2024 and has held it in 6 quarters since. The position peaked at $855K in Q2 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Evelyn Partners Investment Management Services held 2,745 shares of Indivior Pharmaceuticals worth $83.7K as of Q1 2026.
  • Evelyn Partners Investment Management Services left its Indivior Pharmaceuticals share count unchanged in Q1 2026.
  • Indivior Pharmaceuticals made up 0.01% of Evelyn Partners Investment Management Services's portfolio in Q1 2026, its #154 holding.
  • Evelyn Partners Investment Management Services first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management Services's Indivior Pharmaceuticals position peaked at $855K in Q2 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Evelyn Partners Investment Management Services's 13F filing for Q1 2026, filed 15 May 2026.